Related Experiment Video
Updated: Aug 14, 2026
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
[Prognosis in patients with pneumonia and chronic obstructive pulmonary disease]
M Merino-Sánchez1, I Alfageme-Michavila, N Reyes-Núñez
1Servicio de Neumología, Hospital Universitario de Valme, Sevilla, Spain. mercedesmerino@terra.es
Objective:
To study the incidence, severity, and mortality rates of pneumonia in a cohort of chronic obstructive pulmonary disease (COPD) patients monitored over 3 years.
Patients And Methods:
A total of 596 patients diagnosed with COPD according to spirometric criteria were included in the study. The variables assessed were mortality and severity according to the Pneumonia Severity Index (PSI) for community-acquired pneumonia (CAP).
Results:
Of the 596 patients included in the study, 75 (12.6%) developed at least 1 episode of pneumonia during the 3 years of the study. The overall incidence of pneumonia was 55.1 per 1000 person-years. There were 88 episodes in 75 patients. COPD severity, evaluated based on percentage of predicted FEV1, was mild in 9 patients, moderate in 24, and severe in 42. Seventy-six (86.3%) episodes were CAP and 12 (13.6%) were acquired in hospital. Fourteen CAP cases corresponded to PSI group V, 28 to group IV, 20 to group III, and 14 to groups I and II. Overall mortality was 12.5% (11/88). The mortality rate was 41.7% (5/12) for nosocomial cases and 7.8% (6/76) for CAP cases (OR, 6.67; 95% confidence interval, 1.65-26.93). Assessing CAP mortality by level of severity, we found that the mortality rate was 35.7% (5/14) for group V and 3.5% (1/28) for group IV. No deaths occurred among patients in the other severity groups.
Conclusions:
The incidence of pneumonia in COPD patients is high. More than half the cases of CAP (55.2%) in our COPD patients were classified in PSI risk groups IV and V.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
01:30Pneumonia III: Complications and Assessment
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations